Exploring the Role of Glycine Metabolism in Coronary Artery Disease: Insights from Human Genetics and Mouse Models

Overview

Journal Nutrients

Date 2025 Jan 11

PMID 39796632

Authors

Subarna Biswas

James R Hilser

Nicholas C Woodward

Zeneng Wang

Janet Gukasyan

Ina Nemet

William S Schwartzman

Pin Huang

Yi Han

Zachary Fouladian

Sarada Charugundla

Neal J Spencer

Calvin Pan

W H Wilson Tang

Aldons J Lusis

Stanley L Hazen

Jaana A Hartiala

Hooman Allayee

Affiliations

Soon will be listed here.

Abstract

Circulating glycine levels have been associated with reduced risk of coronary artery disease (CAD) in humans but these associations have not been observed in all studies. We evaluated whether the relationship between glycine levels and atherosclerosis was causal using genetic analyses in humans and feeding studies in mice. Serum glycine levels were evaluated for association with risk of CAD in the UK Biobank. Genetic determinants of glycine levels were identified through a genome-wide association study (GWAS) and used to evaluate the causal relationship between glycine and risk of CAD by Mendelian randomization (MR). A dietary supplementation study was carried out with atherosclerosis-prone apolipoprotein E deficient () mice to determine the effects of increased circulating glycine levels on cardiometabolic traits and aortic lesion formation. Among 105,718 UK Biobank subjects, elevated serum glycine levels were associated with significantly reduced risk of prevalent CAD (Quintile 5 vs. Quintile 1 OR = 0.76, 95% CI 0.67-0.87; < 0.0001) and incident CAD (Quintile 5 vs. Quintile 1 HR = 0.70, 95% CI 0.65-0.77; < 0.0001) after adjustment for age, sex, ethnicity, anti-hypertensive and lipid-lowering medications, blood pressure, kidney function, and diabetes. A GWAS meta-analysis with 230,947 subjects identified 61 loci for glycine levels, of which 26 were novel. MR analyses provided modest evidence that genetically elevated glycine levels were causally associated with reduced systolic blood pressure and risk of type 2 diabetes, but did not provide significant evidence for an association with decreased risk of CAD. Glycine supplementation in mice had no effects on cardiometabolic traits or atherosclerotic lesion development. While expanding the genetic architecture of glycine metabolism, MR analyses and in vivo feeding studies did not provide evidence that the clinical association of this amino acid with atherosclerosis represents a causal relationship.

References

Zaric B, Radovanovic J, Gluvic Z, Stewart A, Essack M, Motwalli O . Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes. Front Immunol. 2020; 11:551758. PMC: 7549398. DOI: 10.3389/fimmu.2020.551758. View

Shi Y, Yasui M, Hara-Chikuma M . AQP9 transports lactate in tumor-associated macrophages to stimulate an M2-like polarization that promotes colon cancer progression. Biochem Biophys Rep. 2022; 31:101317. PMC: 9372591. DOI: 10.1016/j.bbrep.2022.101317. View

Yengo L, Sidorenko J, Kemper K, Zheng Z, Wood A, Weedon M . Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry. Hum Mol Genet. 2018; 27(20):3641-3649. PMC: 6488973. DOI: 10.1093/hmg/ddy271. View

Ceron E, Bernal-Alcantara D, Vanda B, Sommer B, Gonzalez-Trujano E, Alvarado-Vasquez N . Glycine supplementation during six months does not alter insulin, glucose or triglyceride plasma levels in healthy rats. Int J Vitam Nutr Res. 2020; 91(5-6):451-460. DOI: 10.1024/0300-9831/a000645. View

Loh P, Tucker G, Bulik-Sullivan B, Vilhjalmsson B, Finucane H, Salem R . Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat Genet. 2015; 47(3):284-90. PMC: 4342297. DOI: 10.1038/ng.3190. View

Chen Y, Lu T, Pettersson-Kymmer U, Stewart I, Butler-Laporte G, Nakanishi T . Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023; 55(1):44-53. PMC: 7614162. DOI: 10.1038/s41588-022-01270-1. View

Mehrabian M, Schulthess F, Nebohacova M, Castellani L, Zhou Z, Hartiala J . Identification of ALOX5 as a gene regulating adiposity and pancreatic function. Diabetologia. 2008; 51(6):978-88. PMC: 2835627. DOI: 10.1007/s00125-008-1002-3. View

Julkunen H, Cichonska A, Tiainen M, Koskela H, Nybo K, Makela V . Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank. Nat Commun. 2023; 14(1):604. PMC: 9898515. DOI: 10.1038/s41467-023-36231-7. View

Leung K, de Castro S, Galea G, Copp A, Greene N . Glycine Cleavage System H Protein Is Essential for Embryonic Viability, Implying Additional Function Beyond the Glycine Cleavage System. Front Genet. 2021; 12:625120. PMC: 7868403. DOI: 10.3389/fgene.2021.625120. View

10.

Hartiala J, Bennett B, Tang W, Wang Z, Stewart A, Roberts R . Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine. Arterioscler Thromb Vasc Biol. 2014; 34(6):1307-13. PMC: 4035110. DOI: 10.1161/ATVBAHA.114.303252. View

11.

Alves A, Bassot A, Bulteau A, Pirola L, Morio B . Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases. Nutrients. 2019; 11(6). PMC: 6627940. DOI: 10.3390/nu11061356. View

12.

Smith M, Bull C, Holmes M, Davey Smith G, Sanderson E, Anderson E . Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study. EBioMedicine. 2023; 90:104503. PMC: 10009453. DOI: 10.1016/j.ebiom.2023.104503. View

13.

Tan H, Hsu J, Tai E, Chacko S, Kovalik J, Jahoor F . The impact of obesity-associated glycine deficiency on the elimination of endogenous and exogenous metabolites via the glycine conjugation pathway. Front Endocrinol (Lausanne). 2024; 15:1343738. PMC: 11023637. DOI: 10.3389/fendo.2024.1343738. View

14.

Spracklen C, Horikoshi M, Kim Y, Lin K, Bragg F, Moon S . Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature. 2020; 582(7811):240-245. PMC: 7292783. DOI: 10.1038/s41586-020-2263-3. View

15.

Hartiala J, Han Y, Jia Q, Hilser J, Huang P, Gukasyan J . Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. Eur Heart J. 2021; 42(9):919-933. PMC: 7936531. DOI: 10.1093/eurheartj/ehaa1040. View

16.

Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S . Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals. Commun Biol. 2019; 2:115. PMC: 6453927. DOI: 10.1038/s42003-019-0339-0. View

17.

Osman W, Hassoun A, Jelinek H, Almahmeed W, Afandi B, Tay G . Genetics of type 2 diabetes and coronary artery disease and their associations with twelve cardiometabolic traits in the United Arab Emirates population. Gene. 2020; 750:144722. DOI: 10.1016/j.gene.2020.144722. View

18.

Hemani G, Zheng J, Elsworth B, Wade K, Haberland V, Baird D . The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018; 7. PMC: 5976434. DOI: 10.7554/eLife.34408. View

19.

Chang C, Chow C, Tellier L, Vattikuti S, Purcell S, Lee J . Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015; 4:7. PMC: 4342193. DOI: 10.1186/s13742-015-0047-8. View

20.

Rom O, Liu Y, Finney A, Ghrayeb A, Zhao Y, Shukha Y . Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis. Redox Biol. 2022; 52:102313. PMC: 9044008. DOI: 10.1016/j.redox.2022.102313. View